Cardax Reports 2019 Annual Results

Author's Avatar
Mar 30, 2020
Article's Main Image

- CHASE clinical trial interim review demonstrated beneficial changes in markers of cardiovascular health

- Composition of matter patent for CDX-101 filed to extend patent coverage to 2040

- ZanthoSyn® sales rebound in the second half of 2019 with stronger correlation of sell-in/sell-through patterns

- $3,360,000 raised in 2019

PR Newswire